Literatur
-
1
Amiel S A, Dixon T, Mann R et al.
Hypoglycaemia in type 2 diabetes.
Diabet Med.
2008;
25
245-254
-
2
Cryer P E.
Hypoglycemia: still the limiting factor in the glycemic management of diabetes.
Endocr Pract.
2008;
14
750-756
-
3
Amiel S A, Cryer P E.
Attenuated sympathoadrenal responses, but not severe hypoglycemia, during aggressive glycemic therapy of early type 2 diabetes.
Diabetes.
2009;
58
515-517
-
4
Fritsche A, Stefan N, Häring H et al.
Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes.
Ann Intern Med.
2001;
134
729-736
-
5
Turnbull F M, Abraira C, Anderson R J et al.
Intensive glucose control and macrovascular outcomes in type 2 diabetes.
Diabetologia.
2009;
52
2288-2298
-
6
Gerstein H C, Miller M E, Byington R P et al.
Effects of intensive glucose lowering in type 2 diabetes.
N Engl J Med.
2008;
358
2545-2559
-
7
Dluhy R G, McMahon G T.
Intensive glycemic control in the ACCORD and ADVANCE trials.
N Engl J Med.
2008;
358
2630-2633
-
8
Whitmer R A, Karter A J, Yaffe K et al.
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus.
Jama.
2009;
301
1565-1572
-
9
Gallwitz B, Haring H U.
Future perspectives for insulinotropic agents in the treatment of type 2 diabetes-DPP-4 inhibitors and sulphonylureas.
Diabetes Obes Metab.
2009;
, [Epub ahead of print]
-
10
Gallwitz B.
The value of incretin based therapies.
Dtsch Med Wochenschr.
2009;
134
1062-1066
-
11
Mullins P, Sharplin P, Yki-Jarvinen H et al.
Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus.
Clin Ther.
2007;
29
1607-1619
-
12
Tschritter O, Fritsche A, Gallwitz B et al.
Langwirkende Insulinanaloga in der Therapie des Diabetes mellitus Typ 1 und Typ 2. Eine Zusammenfassung der klinischen Studien und Metaanalysen.
Diabetes und Stoffwechsel.
2005;
14
375-382
-
13
The Diabetes Control and Complications Trial Research Group .
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
N Engl J Med.
1993;
329
977-986
Prof. Dr. med. Andreas Fritsche
Universität Tübingen · Medizinische Klinik IV
Otfried Müller Straße 10
72076 Tübingen
Email: andreas.fritsche@med.uni-tuebingen.de
